Concepedia

Author

Youxiang Ding

China Pharmaceutical University

Also Known As

Ding Youxiang, You-Xiang DING, Youxiang Ding

21

Publications

491

Citations

12

H-Index

39

Concepts

All Affiliations

China Pharmaceutical UniversityState Key Laboratory of Natural MedicineNanjing Drum Tower HospitalNanjing University of Chinese MedicineNanjing Medical University
YD

About

Youxiang Ding is an author at China Pharmaceutical University specializing in medicine, tumor biology, and cancer cell biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

7

7

254

2

Cell Biology

4

4

111

3

Health Sciences

1

1

41

4

Gastroenterology

1

1

73

5

Hepatology

1

1

41

Youxiang Ding

×

13

Publications

419

Citations

12

H-Index

YearCitations

Oroxyloside prevents dextran sulfate sodium-induced experimental colitis in mice by inhibiting NF-κB pathway through PPARγ activation

Xiaoping Wang, Yang Sun, Yue Zhao,

Biochemical Pharmacology

2016

73

Wogonoside prevents colitis-associated colorectal carcinogenesis and colon cancer progression in inflammation-related microenvironment via inhibiting NF-κB activation through PI3K/Akt pathway

Yang Sun, Yue Zhao, Xiaoping Wang,

Oncotarget

2016

54

c‐Fos separation from Lamin A/C by GDF15 promotes colon cancer invasion and metastasis in inflammatory microenvironment

Youxiang Ding, Kun Hao, Zhaohe Li,

Journal of Cellular Physiology

2019

47

HSP90α Mediates Sorafenib Resistance in Human Hepatocellular Carcinoma by Necroptosis Inhibition under Hypoxia

Yan Liao, Yue Yang, Di Pan,

Cancers

2021

41

GL-V9, a new synthetic flavonoid derivative, ameliorates DSS-induced colitis against oxidative stress by up-regulating Trx-1 expression via activation of AMPK/FOXO3a pathway

Yue Zhao, Yang Sun, Youxiang Ding,

Oncotarget

2015

39

Oroxylin A increases the sensitivity of temozolomide on glioma cells by hypoxia‐inducible factor 1α/hedgehog pathway under hypoxia

Mian Wei, Rong Ma, Shaoliang Huang,

Journal of Cellular Physiology

2019

31

c-Fos regulated by TMPO/ERK axis promotes 5-FU resistance via inducing NANOG transcription in colon cancer

Yanping Gui, Xiaoping Qian, Youxiang Ding,

Cell Death and Disease

2024

29

Oroxylin A reverses the drug resistance of chronic myelogenous leukemia cells to imatinib through CXCL12/CXCR7 axis in bone marrow microenvironment

Wenjun Li, Ding Qi-long, Youxiang Ding,

Molecular Carcinogenesis

2016

28

Vimentin loss promotes cancer proliferation through up-regulating Rictor/AKT/β-catenin signaling pathway

Youxiang Ding, Conggai Lv, You Zhou,

Experimental Cell Research

2021

20

LYG-202 exerts antitumor effect on PI3K/Akt signaling pathway in human breast cancer cells

Yue Zhao, Xiaoping Wang, Yang Sun,

APOPTOSIS

2015

19

Page 1